Three Clinical Trial Challenges—and What They Teach Us About Planning for Success
Clinical trials are complex by design. The most successful projects are not those without challenges—they are the ones prepared to manage them.
Clinical trial design and execution depends on hundreds of interconnected decisions. For CROs, experience is one of the most valuable tools for managing that complexity. Every challenge provides an opportunity to refine processes, strengthen risk management, and improve how future studies are planned and executed.
Below are three clinical project challenges and the lessons they offer for building more resilient clinical trial strategies.
Challenge #1: Insufficient Site Qualification
Selecting a clinical site based primarily on its credentials, patient population, or previous experience may seem like an efficient shortcut, but it can leave important operational questions unanswered. Without proper vetting, some site-specific requirements may emerge only after the activation process is underway which can contribute to significant activation delays.
Effective site qualification assessments should mitigate execution risk by including:
- A deep dive into clinical protocol review, including a focus on operationalizing the protocol at the clinical site
- Investigator engagement and availability
- Study coordinator and treatment staff resources
- Laboratory capabilities and staffing
- Weekend and after-hours coverage
- Third-party personnel or service arrangements
- Institutional contracting requirements
- Equipment and storage capabilities
- Staff turnover risk
- The site’s ability to execute the protocol as written
The lesson: Site qualification is an investment in predictability. Taking the time to identify any operational barriers before activation is significantly easier than resolving them after the study is underway.
Challenge #2: Ambiguity in Study Documentation
A protocol with vague or ambiguous language can lead to inconsistencies in data collection at the site and even subject level. A strong training program during site initiation, and well-designed Case Report Forms (CRF) and CRF Completion Guidelines can mitigate some of these inconsistencies. A protocol that requires extensive clarification in reference documents is likely to lead to problems during the data cleaning phase later.
Protocol and Case Report Forms should have clear and consistent language around the following:
- Eligibility Requirements and Reporting; Guidelines for Screen Failure and Subject Withdrawal
- Assessment and follow-up visit timepoints and windows
- Differentiation between mandated and optional visits and assessments and how they should be reported
- Assessment and reporting of complications and adverse events
- Appropriate detail on imaging requirements if required for the study (conventional imaging or are certain views required)
- Protocol Deviations
The lesson: As much as possible, eliminate any ambiguity in protocol language to avoid inconsistency in site interpretation of instructions, improve data collection and reduce data cleaning burden. CRF training should consist of an active, hands on completion by the study coordinator in order to maximize learning.
Challenge #3: Disconnect Between Study Execution Plans and Vendor Contracts
Clinical trial execution depends on alignment between the protocol, operational plans, vendors, contracts, and budgets. A disconnect between these documents can create significant delays, but is often overlooked due to the many different functions that are engaged in these efforts.
For example, a Sponsor’s data-review charter written by a Data Management team may require multiple interim data transfers, while the applicable laboratory contract negotiated by a Legal Representative may only include a single, final data transfer. Additional contracting requirements can delay planned data transfer and review, impacting the Sponsor’s ability to hit study milestones.
Before initiation, CRO teams should cross-check:
- Protocol requirements
- Data review plans and data transfer specifications
- Statistical requirements
- Laboratory manuals
- Vendor scopes of work
- Contracts
The Lesson: Some cross-functional engagement is required to ensure that vendor contracting is fully aligned with operational requirements.
From Lessons Learned to Better Outcomes
No clinical trial is immune to challenges. What distinguishes resilient projects is not the absence of problems, but the ability to anticipate, identify, communicate, and respond to risk before it becomes a critical issue.
Ultimately, successful clinical trial management is about more than keeping a study on schedule. It is about creating the conditions that make success possible.
Plan early. Identify dependencies. Define ownership. Challenge assumptions. And build contingencies before they are needed.
That is how clinical project teams turn experience into better execution.
